Application 213950
- Type
- ANDA
- Sponsor
- AMNEAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ETHINYL ESTRADIOL AND NORELGESTROMIN | ETHINYL ESTRADIOL; NORELGESTROMIN | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.035MG/24HR;0.15MG/24HR | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65162-358 | ZAFEMY | Norelgestromin and Ethinly Estradiol | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-358 | ZAFEMY | Norelgestromin and Ethinly Estradiol | Amneal Pharmaceuticals LLC | ANDA | Current |
| 69238-1521 | Norelgestromin and Ethinly Estradiol | Norelgestromin and Ethinly Estradiol | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1521 | Norelgestromin and Ethinly Estradiol | Norelgestromin and Ethinly Estradiol | Amneal Pharmaceuticals NY LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79316 | ORIG | 2024-08-06 |